Back to Awarded Treatment Trials
Awarded Trial: 05T-681
Grant ID
05T-681
Illness
Bipolar Depression
Primary Drug/Intervention
Levetiracetam
Primary Dosage
2000 mg/day
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Bhagwagar
Sample Size
50
Duration of Study Period for Each Subject
6 weeks
Outcome Measurements
HDRS, YMRS, MADRS
Results
Thirty-two patients with bipolar depression were treated with levetiracetam up to 2000 mg/d or placebo for 6 weeks. No differences were found on any measures between the two groups.
Publication
Saricicek A, Maloney K, Muralidharan A et al. Levetiracetam in the management of bipolar depression: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2010 Oct 19 [Epub ahead of print].
Link
http://www.ncbi.nlm.nih.gov/pubmed/21034692
PI Name
Zubin Bhagwagar
Degree
MD
Center
N/A
Institution
Yale University School of Medicine
Address
34 Park Street
City or Town
New Haven
State or Province
CT
Zip or Postal Code
6511
Country
USA
Email Address
zubin.bhagwagar@yale.edu